Drugs / HSVTI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05989672 | Aug → Nov 2023 | herpes simplex infectious disease | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HSVTI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05989672 ↗ |
| Route | Intramuscular | “This investigational intervention was administered intramuscularly to HSVTI\_F1 Group.” NCT05989672 ↗ |